371 related articles for article (PubMed ID: 35695895)
1. Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies.
Diesler R; Cottin V
Expert Rev Respir Med; 2022 May; 16(5):541-553. PubMed ID: 35695895
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia.
Manfredi A; Luppi F; Cassone G; Vacchi C; Salvarani C; Sebastiani M
Expert Rev Clin Immunol; 2020 Aug; 16(8):751-770. PubMed ID: 32722946
[TBL] [Abstract][Full Text] [Related]
3. The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease.
Spagnolo P; Lee JS; Sverzellati N; Rossi G; Cottin V
Arthritis Rheumatol; 2018 Oct; 70(10):1544-1554. PubMed ID: 29806092
[TBL] [Abstract][Full Text] [Related]
4. Potential Rheumatoid Arthritis-Associated Interstitial Lung Disease Treatment and Computational Approach for Future Drug Development.
Jeong E; Hong H; Lee YA; Kim KS
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473928
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in rheumatoid arthritis-associated interstitial lung disease.
Juge PA; Crestani B; Dieudé P
Curr Opin Pulm Med; 2020 Sep; 26(5):477-486. PubMed ID: 32701675
[TBL] [Abstract][Full Text] [Related]
6. Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population.
Zheng W; Hu X; Zou M; Hu N; Song W; Wang R; Liu Y; Hou Q; Liu Y; Chen X; Cheng Z
Inflammation; 2023 Feb; 46(1):285-296. PubMed ID: 36044099
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis related interstitial lung disease.
Manfredi A; Cassone G; Luppi F; Atienza-Mateo B; Cavazza A; Sverzellati N; González-Gay MA; Salvarani C; Sebastiani M
Expert Rev Clin Immunol; 2021 May; 17(5):485-497. PubMed ID: 33779447
[TBL] [Abstract][Full Text] [Related]
8. Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study.
Dubey S; Woodhead F
Rheumatol Int; 2024 Jan; 44(1):99-105. PubMed ID: 38085367
[TBL] [Abstract][Full Text] [Related]
9. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
[TBL] [Abstract][Full Text] [Related]
10. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
Zhang J; Wang D; Wang L; Wang S; Roden AC; Zhao H; Li X; Prakash YS; Matteson EL; Tschumperlin DJ; Vassallo R
Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L487-L497. PubMed ID: 30604628
[TBL] [Abstract][Full Text] [Related]
11. Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Koduri G; Solomon JJ
Arthritis Rheumatol; 2023 Dec; 75(12):2067-2077. PubMed ID: 37395725
[TBL] [Abstract][Full Text] [Related]
12. Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease.
Bes C; Köybaşı G; İçaçan OC; Yalçın Mutlu M; Yıldırım F
Eur J Rheumatol; 2022 Jul; 9(3):176-179. PubMed ID: 35156636
[TBL] [Abstract][Full Text] [Related]
13. [Latest news on RA-ILD].
Schreiber T; Hagmeyer L; Kofler DM; Kubacki T; Frank K; Randerath WJ
Pneumologie; 2022 Sep; 76(9):614-621. PubMed ID: 36104017
[TBL] [Abstract][Full Text] [Related]
14. Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis.
Wu X; Jeong Y; Poli de Frías S; Easthausen I; Hoffman K; Oromendia C; Taheri S; Esposito AJ; Quesada Arias L; Ayaub EA; Maurer R; Gill RR; Hatabu H; Nishino M; Frits ML; Iannaccone CK; Weinblatt ME; Shadick NA; Dellaripa PF; Choi AMK; Kim EY; Rosas IO; Martinez FJ; Doyle TJ
Thorax; 2022 Oct; 77(10):1041-1044. PubMed ID: 35907639
[TBL] [Abstract][Full Text] [Related]
15. Pathological Insight into 5-HT
Löfdahl A; Tornling G; Wigén J; Larsson-Callerfelt AK; Wenglén C; Westergren-Thorsson G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379351
[TBL] [Abstract][Full Text] [Related]
16. Predictors of progression in rheumatoid arthritis-associated interstitial lung disease: A single-center retrospective study from China.
Liu L; Fang C; Sun B; Bao R; Zhang H
Int J Rheum Dis; 2022 Jul; 25(7):795-802. PubMed ID: 35633522
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
Chen N; Diao CY; Gao J; Zhao DB
Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol attenuates inflammation and fibrosis in rheumatoid arthritis-associated interstitial lung disease via the AKT/TMEM175 pathway.
Liu N; Fan X; Shao Y; Chen S; Wang T; Yao T; Chen X
J Transl Med; 2024 May; 22(1):457. PubMed ID: 38745204
[TBL] [Abstract][Full Text] [Related]
19. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.
Matson SM; Baqir M; Moua T; Marll M; Kent J; Iannazzo NS; Boente RD; Donatelli JM; Dai J; Diaz FJ; Demoruelle MK; Hamblin MB; Mathai SK; Ryu JH; Pope K; Walker CM; Lee JS
Chest; 2023 Apr; 163(4):861-869. PubMed ID: 36470416
[TBL] [Abstract][Full Text] [Related]
20. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
